{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:06:56Z","timestamp":1778177216741,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jinf.2005.01.006","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T19:44:46Z","timestamp":1109447086000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections"],"prefix":"10.1016","volume":"52","author":[{"given":"Y.","family":"Nivoix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zamfir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lutun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lioure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Rigolot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Entz-Werl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Letscher-Bru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lev\u00eaque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Koffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Beretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.01.006_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2005.01.006_bib2","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2005.01.006_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-3062.1999.010406.x","article-title":"Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability","volume":"1","author":"Tiphine","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1201-9712(03)90003-8","article-title":"Caspofungin in the treatment of candidosis and aspergillosis","volume":"7","author":"Maertens","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2003.08.003","article-title":"Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far","volume":"6","author":"Kontoyiannis","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jinf.2005.01.006_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.006_bib8","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.006_bib9","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.46.9.3039-3041.2002","article-title":"In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp","volume":"46","author":"Perea","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.01.006_bib10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2005.01.006_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2005.01.006_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ajhp\/59.1.80","article-title":"Combination therapy with caspofungin and amphotericin B lipid complex","volume":"59","author":"Lum","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jinf.2005.01.006_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/340260","article-title":"Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole","volume":"34","author":"Safdar","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.inf.0000073060.20277.29","article-title":"Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis","volume":"22","author":"Elanjikal","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2005.01.006_bib16","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/339755","article-title":"Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans","volume":"34","author":"Rubin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.01.006_bib18","unstructured":"Maertens J, Glasmacher A, Herbrecht R, Cordonnier C, Segal B, Aoun M, et al. Multicenter noncomparative study of caspofungin combined with other antifungals in adults with invasive aspergillosis refractory or intolerant to standard regimen. Proceedings of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 30\u2013November 2; 2004, p. 14 [Abstract M-671a, addendum]."},{"key":"10.1016\/j.jinf.2005.01.006_bib19","unstructured":"Meletiadis J, Petraitis V, Petraitiene R, Kelaher A, Murray H, Maya-San C, et al. Antagonistic interaction between liposomal amphotericin B and ravuconazole in experimental invasive pulmonary aspergillosis: implications for combination therapy. Proceedings of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 30\u2013November 2; 2004, p. 403 [Abstract M-238]."},{"key":"10.1016\/j.jinf.2005.01.006_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2165\/00003495-200161080-00007","article-title":"Caspofungin","volume":"61","author":"Keating","year":"2001","journal-title":"Drugs"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:10Z","timestamp":1758986950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0163445305000162"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.01.006","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}